Page-10 of COVID-19 vaccine

SBI Report: FY22 growth at 10.4%,

The State Bank of India recently revised the growth of India for the Fiscal Year 2021-22 to 10.4%. Earlier, the bank had predicted the growth rate as 11%. SBI has curbed the growth rate of the country due to the ..

Month: 

IndRa: Cost of vaccinating India’s population above 18 years 0.36% of GDP

The India Ratings and Research (Ind-Ra) recently said the estimated cost to vaccinate all the Indians of age 18 years will be Rs 67,193 crores. This is 0.36% of the GDP of the country. Key Findings The GoI recently announced ..

Month: 

COVAXIN: Transfer of Technology from Bharat Biotech to Haffkine

The Government of India recently approved the transfer of technology from Bharat Biotech to Hafkine Institute. COVAXIN COVAXIN is one of the two drugs that is currently administered in India. It is manufactured by Bharat Biotech in collaboration with the ..

Month: 

IMF: Sub-Saharan Africa to see world’s slowest growth in 2021

The International Monetary Fund recently released the Regional Economic Outlook for Sub Saharan Africa. According to the report the Sub Saharan region is to witness the world’s slowest growth in 2021. Key Findings The sub-Saharan region is projected to grow ..

Month: 

What is Adenovirus?

The US health authorities recently paused the rollout of one-shot Johnson and Johnson COVID-19 vaccine. The vaccine uses similar technology as that of the Astra Zeneca vaccine. Both the vaccines are developed from adenoviral vectors. Why did the US stop ..

Month: 

Bhutan: 93% of adults vaccinated in 16 days

The Himalayan kingdom Bhutan has recently completed vaccinating 93% of its adult population in the world. How did Bhutan succeed in its vaccination programme? The population of Bhutan is small. This is one of the main reason behind the rapid ..

Month: